Literature DB >> 2326543

Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.

M Ishikawa1, Y Takayanagi, K Sasaki.   

Abstract

Pretreatment of buthionine sulfoximine (500 mg/kg, i.p., BSO), a potent glutathione-depleting agent, markedly increased the lethality and nephrotoxicity of cisplatin. These results suggest that a reactive electrophilic intermediate may be involved in the mechanism of cisplatin nephrotoxicity and moreover, that renal glutathione may play a protective role against cisplatin-induced nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2326543

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  6 in total

1.  A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors.

Authors:  J T Hartmann; L M Fels; S Knop; H Stolt; L Kanz; C Bokemeyer
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

Review 2.  WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.

Authors:  M Treskes; W J van der Vijgh
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.

Authors:  C Bokemeyer; L M Fels; T Dunn; W Voigt; J Gaedeke; H J Schmoll; H Stolte; H Lentzen
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

4.  The Protective Effect of Naringenin-Oxime on Cisplatin-Induced Toxicity in Rats.

Authors:  Ismail Koyuncu; Abdurrahim Kocyigit; Ataman Gonel; Erkan Arslan; Mustafa Durgun
Journal:  Biochem Res Int       Date:  2017-08-28

5.  Protective effect of cactus cladode extract against cisplatin induced oxidative stress, genotoxicity and apoptosis in balb/c mice: combination with phytochemical composition.

Authors:  Dalel Brahmi; Yousra Ayed; Mbarka Hfaiedh; Chayma Bouaziz; Hedi Ben Mansour; Lazhar Zourgui; Hassen Bacha
Journal:  BMC Complement Altern Med       Date:  2012-07-31       Impact factor: 3.659

6.  Enhancement of antitumor activity of cisplatin on human gastric cancer cells in vitro and in vivo by buthionine sulfoximine.

Authors:  Y Saikawa; T Kubota; T H Kuo; T Furukawa; H Tanino; M Watanabe; K Ishibiki; M Kitajima
Journal:  Jpn J Cancer Res       Date:  1993-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.